JP2022517329A5 - - Google Patents
Info
- Publication number
- JP2022517329A5 JP2022517329A5 JP2021539522A JP2021539522A JP2022517329A5 JP 2022517329 A5 JP2022517329 A5 JP 2022517329A5 JP 2021539522 A JP2021539522 A JP 2021539522A JP 2021539522 A JP2021539522 A JP 2021539522A JP 2022517329 A5 JP2022517329 A5 JP 2022517329A5
- Authority
- JP
- Japan
- Prior art keywords
- labyrintin
- isolated anti
- antibody
- construct according
- labyrinthin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024218292A JP2025060688A (ja) | 2019-01-08 | 2024-12-13 | ラビリンチン又はその一部を標的とする構築物及びその使用 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962789871P | 2019-01-08 | 2019-01-08 | |
| US62/789,871 | 2019-01-08 | ||
| PCT/US2020/012613 WO2020146413A1 (en) | 2019-01-08 | 2020-01-07 | Constructs targeting labyrinthin or a portion thereof and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218292A Division JP2025060688A (ja) | 2019-01-08 | 2024-12-13 | ラビリンチン又はその一部を標的とする構築物及びその使用 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022517329A JP2022517329A (ja) | 2022-03-08 |
| JP2022517329A5 true JP2022517329A5 (https=) | 2023-01-19 |
Family
ID=71520309
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021539522A Pending JP2022517329A (ja) | 2019-01-08 | 2020-01-07 | ラビリンチン又はその一部を標的とする構築物及びその使用 |
| JP2024218292A Pending JP2025060688A (ja) | 2019-01-08 | 2024-12-13 | ラビリンチン又はその一部を標的とする構築物及びその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024218292A Pending JP2025060688A (ja) | 2019-01-08 | 2024-12-13 | ラビリンチン又はその一部を標的とする構築物及びその使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220089719A1 (https=) |
| EP (1) | EP3908612A4 (https=) |
| JP (2) | JP2022517329A (https=) |
| KR (1) | KR20210137997A (https=) |
| CN (1) | CN113993892A (https=) |
| AU (1) | AU2020206329A1 (https=) |
| CA (1) | CA3126063A1 (https=) |
| IL (1) | IL284638A (https=) |
| MX (1) | MX2021008205A (https=) |
| TW (1) | TW202043270A (https=) |
| WO (1) | WO2020146413A1 (https=) |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6166176A (en) * | 1998-03-17 | 2000-12-26 | Immvarx, Inc. | Cancer marker protein and peptides thereof |
| EP1789447B1 (en) * | 2004-08-16 | 2012-04-25 | Immune Disease Institute, Inc. | Method of delivering rna interference and uses thereof |
| WO2011116014A2 (en) * | 2010-03-15 | 2011-09-22 | Mission Therapeutics, Inc. | Humanized antibodies to labyrinthin and uses thereof |
| US20110230433A1 (en) * | 2010-03-16 | 2011-09-22 | University Of Washington | Compositions and methods for treatment of cancer |
| JP6117515B2 (ja) * | 2011-11-01 | 2017-04-19 | 国立大学法人名古屋大学 | 髄膜腫治療用医薬組成物 |
| WO2016134284A1 (en) * | 2015-02-19 | 2016-08-25 | University Of Florida Research Foundation, Inc. | Chimeric antigen receptors and uses thereof |
| WO2016161390A1 (en) * | 2015-04-03 | 2016-10-06 | Eureka Therapeutics, Inc. | Constructs targeting afp peptide/mhc complexes and uses thereof |
| CA3021634A1 (en) * | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
| AU2018257894A1 (en) * | 2017-04-24 | 2019-10-31 | Kite Pharma, Inc. | Humanized antigen-binding domains against CD19 and methods of use |
| WO2019217913A1 (en) * | 2018-05-10 | 2019-11-14 | Sensei Biotherapeutics, Inc. | Aspartate beta-hydroxylase chimeric antigen receptors and uses thereof |
-
2020
- 2020-01-07 US US17/309,955 patent/US20220089719A1/en active Pending
- 2020-01-07 MX MX2021008205A patent/MX2021008205A/es unknown
- 2020-01-07 AU AU2020206329A patent/AU2020206329A1/en active Pending
- 2020-01-07 JP JP2021539522A patent/JP2022517329A/ja active Pending
- 2020-01-07 KR KR1020217025039A patent/KR20210137997A/ko not_active Ceased
- 2020-01-07 CN CN202080017505.2A patent/CN113993892A/zh active Pending
- 2020-01-07 EP EP20738867.9A patent/EP3908612A4/en active Pending
- 2020-01-07 WO PCT/US2020/012613 patent/WO2020146413A1/en not_active Ceased
- 2020-01-07 CA CA3126063A patent/CA3126063A1/en active Pending
- 2020-01-08 TW TW109100669A patent/TW202043270A/zh unknown
-
2021
- 2021-07-06 IL IL284638A patent/IL284638A/en unknown
-
2024
- 2024-12-13 JP JP2024218292A patent/JP2025060688A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112646031B (zh) | 抗4-1bb纳米抗体及其用途 | |
| JP2019116474A5 (https=) | ||
| JP2020525032A5 (https=) | ||
| JP2018512145A5 (https=) | ||
| JP2019505564A5 (https=) | ||
| JP2023508174A5 (https=) | ||
| JP2022548777A5 (https=) | ||
| CN112745392B (zh) | 抗pd-l1/cd47双特异性抗体及其用途 | |
| JP2019511201A5 (https=) | ||
| JP2022545655A5 (https=) | ||
| JP2022513050A5 (https=) | ||
| CN110036028A (zh) | 抗il1-rap抗体 | |
| JP2023524102A5 (https=) | ||
| JP2024001073A5 (https=) | ||
| JP2020534012A5 (https=) | ||
| JP2019505166A5 (https=) | ||
| JP2019504615A5 (https=) | ||
| JP2023508173A5 (https=) | ||
| JP2023502990A5 (https=) | ||
| WO2021047386A1 (zh) | 靶向caix抗原的纳米抗体及其应用 | |
| JP2024515560A5 (https=) | ||
| CN117083301A (zh) | 特异性识别磷脂酰肌醇蛋白聚糖3的单克隆抗体及其应用 | |
| JP2023536631A5 (https=) | ||
| US11306151B2 (en) | Anti-TIP-1 antibodies and uses thereof | |
| JP2024514830A5 (https=) |